The role of reciprocal activation mechanism between STAT3 and PRMT5 in lung cancer

被引:0
作者
Sano, Takumi [1 ,2 ]
Abe, Yoshinori [1 ]
Tanaka, Nobuyuki [1 ]
机构
[1] Nippon Med Sch, Inst Adv Sci, Dept Mol Oncl, Tokyo, Japan
[2] Nippon Med Sch, Sch Med, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3044
引用
收藏
页码:2055 / 2055
页数:1
相关论文
共 50 条
[21]   Inhibition of PRMT5 results in radiosensitization in lung cancer cell lines [J].
Sharma, Smitha ;
Wu, X. ;
Smith, P. ;
Denko, N. ;
Li, C. ;
Lai, H. ;
Yan, F. ;
Shilo, K. ;
Chakravarti, A. ;
Sif, S. ;
Baiocchi, R. ;
Otterson, G. ;
Xu-Welliver, Meng .
CANCER RESEARCH, 2014, 74 (19)
[22]   Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity [J].
Wu, Chin-Jui ;
Sundararajan, Vignesh ;
Sheu, Bor-Ching ;
Huang, Ruby Yun-Ju ;
Wei, Lin-Hung .
CANCERS, 2020, 12 (01)
[23]   Reciprocal roles of STAT3 and STAT5 in nasal polyposis [J].
Wang, Xiao-Qiang ;
Hu, Guo-hua ;
Kou, Wei ;
Shen, Yang ;
Kang, Hou-Yong ;
Hong, Su-Ling .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2012, 33 (06) :741-752
[24]   Reciprocal Activation Between PLK1 and Stat3 Contributes to Survival and Proliferation of Esophageal Cancer Cells [J].
Zhang, Yu ;
Du, Xiao-Li ;
Wang, Cheng-Ji ;
Lin, De-Chen ;
Ruan, Xia ;
Feng, Yan-Bin ;
Huo, Yan-Qiu ;
Peng, Haiyong ;
Cui, Jing-Lu ;
Zhang, Tong-Tong ;
Wang, Yong-Quan ;
Zhang, Hongbing ;
Zhan, Qi-Min ;
Wang, Ming-Rong .
GASTROENTEROLOGY, 2012, 142 (03) :521-U178
[25]   Feedback Activation of STAT3 as a Cancer Drug-Resistance Mechanism [J].
Zhao, Chengguang ;
Li, Huameng ;
Lin, Huey-Jen ;
Yang, Shulin ;
Lin, Jiayuh ;
Liang, Guang .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2016, 37 (01) :47-61
[26]   Stat3 activation in acute lung injury [J].
Gao, H ;
Ward, PA .
FASEB JOURNAL, 2004, 18 (04) :A553-A554
[27]   Stat3 activation in acute lung injury [J].
Gao, HW ;
Guo, RF ;
Speyer, CL ;
Reuben, J ;
Neff, TA ;
Hoesel, LM ;
Riedemann, NC ;
McClintock, SA ;
Sarma, JV ;
Van Rooijen, N ;
Zetoune, FS ;
Ward, PA .
JOURNAL OF IMMUNOLOGY, 2004, 172 (12) :7703-7712
[28]   A comprehensive investigation of PRMT5 in the prognosis and ion channel features of lung cancer [J].
Wang, Yan ;
Chu, Daifang ;
Li, Haichao ;
Fan, Jiangjiang ;
Zhu, Ximing ;
Ma, Yulong ;
Gu, Zhongping ;
Xie, Nianlin ;
Jing, Pengyu .
FRONTIERS IN ONCOLOGY, 2024, 14
[29]   PTPRT epigenetic silencing defines lung cancer with STAT3 activation and can direct STAT3 targeted therapies [J].
Sen, Malabika ;
Kindsfather, Audrey ;
Danilova, Ludmila ;
Zhang, Feng ;
Colombo, Raffaele ;
LaPorte, Matthew G. ;
Kurland, Brenda F. ;
Huryn, Donna M. ;
Wipf, Peter ;
Herman, James G. .
EPIGENETICS, 2020, 15 (6-7) :604-617
[30]   PRMT5/FGFR3/AKT Signaling Axis Facilitates Lung Cancer Cell Metastasis [J].
Zheng, Yonghua ;
Lu, Jingjing ;
Hu, Xiaoyan ;
Hu, Xiaobiao ;
Gao, Xiwen ;
Zhou, Jie .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22